These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38409483)
21. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE Yan J; Li M; Wang XD; Lu ZY; Ni XL Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379 [TBL] [Abstract][Full Text] [Related]
22. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice. Zhao J; Wang Z; Yuan Z; Lv S; Su Q Diab Vasc Dis Res; 2020; 17(6):1479164120977441. PubMed ID: 33269624 [TBL] [Abstract][Full Text] [Related]
23. Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome. Zhang X; Wang Z; Li X; Chen J; Yu Z; Li X; Sun C; Hu L; Wu M; Liu L J Ethnopharmacol; 2023 Jun; 309():116304. PubMed ID: 36870461 [TBL] [Abstract][Full Text] [Related]
24. Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway. Hou C; Jiang X; Sheng W; Zhang Y; Lin Q; Hong S; Zhao J; Wang T; Ye X J Ethnopharmacol; 2024 Jan; 319(Pt 2):117240. PubMed ID: 37777030 [TBL] [Abstract][Full Text] [Related]
25. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis. Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579 [TBL] [Abstract][Full Text] [Related]
26. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE Tang G; Duan F; Li W; Wang Y; Zeng C; Hu J; Li H; Zhang X; Chen Y; Tan H Biomed Pharmacother; 2019 Nov; 119():109410. PubMed ID: 31518877 [TBL] [Abstract][Full Text] [Related]
27. TRIM64 promotes ox-LDL-induced foam cell formation, pyroptosis, and inflammation in THP-1-derived macrophages by activating a feedback loop with NF-κB via IκBα ubiquitination. Zhu C; Chen W; Cui H; Huang Z; Ding R; Li N; Wang Q; Wu F; Zhao Y; Cong X Cell Biol Toxicol; 2023 Jun; 39(3):607-620. PubMed ID: 36229750 [TBL] [Abstract][Full Text] [Related]
28. Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis. Zhao J; Cui L; Sun J; Xie Z; Zhang L; Ding Z; Quan X Cell Signal; 2020 Dec; 76():109781. PubMed ID: 32947021 [TBL] [Abstract][Full Text] [Related]
29. Macrophages regulate plaque progression in diabetic Apoe Liu WX; Hu YF; Tai GJ; Li YP; Li JP; Qiu S; Zheng RF; Damdinjav D; Otieno JN; Li XX; Xu M Atherosclerosis; 2024 Oct; 397():118556. PubMed ID: 39222595 [TBL] [Abstract][Full Text] [Related]
30. Exposure of cigarette smoke condensate activates NLRP3 inflammasome in THP-1 cells in a stage-specific manner: An underlying role of innate immunity in atherosclerosis. Mehta S; Dhawan V Cell Signal; 2020 Aug; 72():109645. PubMed ID: 32305666 [TBL] [Abstract][Full Text] [Related]
31. Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress. Xu Y; Yuan Q; Cao S; Cui S; Xue L; Song X; Li Z; Xu R; Yuan Q; Li R Biochem Biophys Res Commun; 2020 Sep; 529(4):998-1004. PubMed ID: 32819611 [TBL] [Abstract][Full Text] [Related]
32. Sestrin1 inhibits oxidized low-density lipoprotein-induced activation of NLRP3 inflammasome in macrophages in a murine atherosclerosis model. Keping Y; Yunfeng S; Pengzhuo X; Liang L; Chenhong X; Jinghua M Eur J Immunol; 2020 Aug; 50(8):1154-1166. PubMed ID: 32297666 [TBL] [Abstract][Full Text] [Related]
33. Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis. Li X; Zhang Y; Xia M; Gulbins E; Boini KM; Li PL PLoS One; 2014; 9(1):e87552. PubMed ID: 24475307 [TBL] [Abstract][Full Text] [Related]
34. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE Du X; Jiang S; Zeng X; Zhang J; Pan K; Zhou J; Xie Y; Kan H; Song W; Sun Q; Zhao J Toxicol Lett; 2018 Jun; 290():123-132. PubMed ID: 29571893 [TBL] [Abstract][Full Text] [Related]
35. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3. Yan CY; Ouyang SH; Wang X; Wu YP; Sun WY; Duan WJ; Liang L; Luo X; Kurihara H; Li YF; He RR Phytomedicine; 2021 Jan; 80():153398. PubMed ID: 33130474 [TBL] [Abstract][Full Text] [Related]
36. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation. Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882 [TBL] [Abstract][Full Text] [Related]
37. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis. Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315 [TBL] [Abstract][Full Text] [Related]
38. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation. Peng K; Liu L; Wei D; Lv Y; Wang G; Xiong W; Wang X; Altaf A; Wang L; He D; Wang H; Qu P Int J Mol Med; 2015 May; 35(5):1179-88. PubMed ID: 25761252 [TBL] [Abstract][Full Text] [Related]
39. ClC-2 inhibition prevents macrophage foam cell formation by suppressing Nlrp3 inflammasome activation. Ding W; Li J; Wang L; Zhang M; Zheng F Biosci Biotechnol Biochem; 2020 Oct; 84(10):2096-2103. PubMed ID: 32657644 [TBL] [Abstract][Full Text] [Related]
40. Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Zhai Y; Meng X; Luo Y; Wu Y; Ye T; Zhou P; Ding S; Wang M; Lu S; Zhu L; Sun G; Sun X Oncotarget; 2018 Feb; 9(10):9344-9363. PubMed ID: 29507694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]